International Patent: COMPOUNDS AS MODULATORS OF IGF-1R AND USES THEREOF

GENEVA, July 27 -- AMGEN INC. filed a patent application (US2026/011232) for “COMPOUNDS AS MODULATORS OF IGF-1R AND USES THEREOF”. With publication no. WO/2026/156056, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 471/04

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....